ICT BIO 2008 - Combining the Power of ICT with Biomedical Sciences

Major diseases like cancer, neurological and cardiovascular diseases are complex in nature involving environmental, life style, ageing and genetic components. One of the future challenges is to integrate the knowledge of all these different components into robust and fully reliable computer models and "in silico" environments that will help the development and testing of new therapies for better prediction and prevention tools in healthcare.

An integrative research approach is therefore required to better understand the complex mechanisms behind human diseases. In this approach, all processes that occur at multiple levels from molecules to cells, organs and organisms are seen not as separate events but as parts of a multi-scale system which aims at improving the understanding of the human health and diseases.

To face this challenge a new generation of multidisciplinary science fields is emerging at the crossroads of Information Technology, Medicine and Biology that provide "in silico" multi-scale modeling and simulation in medicine and biology. For example, patient-specific computer models of human cells or organs can bring new understanding of disease, support discovery of new drugs or can help visualising the effects of different choices of treatments.

To realise this ambitious vision at the crossroads of Information and Communication Technologies and Biomedical Sciences, researchers from different disciplines must work together on virtually everything that can be observed and measured at multiple biological levels in relation to human physiological diseases. The European Commission is investing in this topic through complementary research programmes in Information and Communication Technologies and Health research.

The Directorate-General Information Society and Media (DG INFSO) supports this integrative research through funding of projects in the area of multi-scale modeling and simulation known as the "Virtual Physiological Human" (VPH) initiative. The Directorate-General Research (DG RTD) supports through funding of projects in the areas of health research and systems biology.

The conference will take place over two days (Oct. 23-24). Each day will start with a plenary session featuring high-level policy speakers including EU Commissioners, Member of Parliaments, prominent scientists and international funding agency representatives from the EU, US and beyond.

In the afternoon, parallel sessions will focus on themes incorporating ICT and life sciences such as multi-scale modeling in cancer research, heart and cardiovascular diseases, muscular-skeleton systems, and ageing. The conference website is updated regularly with the latest information on the sessions and exhibition.

Media events (press-conference, press release, demos to media) will communicate to non-specialists the importance of the synergy between ICT, Biomedical Sciences and Health research and the concrete benefits for all citizens in terms of better healthcare.

During both days an exhibition will be held at the conference venue showcasing amongst others 3D medical imaging and prototypes, interactive audiovisual and technical demonstrations. These demos will be exhibited by on-going research projects showing concrete results in this multidisciplinary research field. The exhibition will be a great opportunity for the public to see the applications of the latest technologies and new tools that will help the development of novel therapies for a more predictive and preventive healthcare.

The Conference is free of charge and online registration is compulsory, entrance will not be permitted without the confirmation letter.

Please note that as the number of seats in the meeting rooms is limited, the Commission reserves the right to confirm, on a free selection basis, only as many registrations as seats available. The confirmation of attendance letter will be sent at the latest on 15th September.

Have Your Say
Logged-in site visitors are able to use the site's 'Comment' function to show their interest in or comment on the event in one of two ways:

  • suggest a contribution - your idea will be forwarded to the session coordinator. If successful, you will be able to develop it further by adding documents;
  • comment on a session - relevant questions and comments will be communicated to the chairman of the session and potentially addressed during the session.

Alongside the conference, the 1st Transatlantic Workshop on Multiscale Cancer Modelling will take place at the same venue.

Computational and mathematical cancer modelling is already a driving force behind interdisciplinary cancer systems biology. Understanding cancer as a complex dynamic bio system requires finding ways to investigate and ultimately target its many constituents and their dynamic relationships across multiple scales in space and time - i.e., multi-scale modelling and simulation. Geared towards translation into clinical practice, long term goals of these modelling approaches include supporting patient specific treatment optimization.

In recognizing the significant contribution of teams on both sides of the Atlantic to this emergent field of in silico oncology, the US National Cancer Institute and the European Commission jointly support a workshop that is being co-organized by NCI’s Center for the Development of a Virtual Tumor, CViT, and EC's Advancing Clinico Genomics Trials Program, ACGT.

This workshop aims to present cutting edge approaches, to demonstrate the field's potential and to discuss common challenges it faces in moving forward. The ideal outcome is facilitated interaction between the teams, increased visibility of the achievements beyond the nascent community and formulation of a shared vision that can be advanced into joint funding programs.

The following modelling and simulation topics will be addressed: carcinogenesis, prevascular and vascular progression, invasion and metastasis, tumour growth across spatiotemporal scales and clinically oriented tumour modelling. All major multilevel approaches i.e. bottom-up, top-down and middle-out will be delineated through carefully selected paradigms. Initiatives regarding translation of multiscale cancer models into the arena of clinical trials will be outlined and their potential will be discussed.

Programme is available at the ICT BIO conference website under the Transatlantic Workshop button.

For further information and registration, please visit:
http://ec.europa.eu/information_society/
events/ict_bio/2008/index_en.htm

Related news articles:

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...